Camelids produce functional antibodies devoid of light chains of which the single N-terminal domain is fully capable of antigen binding. These single-domain antibody fragments (VHHs or Nanobodies®) have several advantages for biotechnological applications. They are well expressed in microorganisms and have a high stability and solubility. Furthermore, they are well suited for construction of larger molecules and selection systems such as phage, yeast, or ribosome display. This minireview offers an overview of (1) their properties as compared to conventional antibodies, (2) their production in microorganisms, with a focus on yeasts, and (3) their therapeutic applications
© 2020 Cheloha et al. Published under exclusive license by The American Society for Biochemistry and...
Single-domain antibodies, derived from camelid heavy antibodies (nanobodies) or shark variable new a...
Nanobodies (or variable domain of the heavy chain of the heavy-chain antibodies, VHHs) are single-do...
Camelids produce functional antibodies devoid of light chains of which the single N-terminal domain ...
Camelids produce functional antibodies devoid of light chains of which the single N-terminal domain ...
The discovery of heavy-chain-only antibodies (HCAbs) in camelids and sharks led to the rise of a new...
Antibodies are important tools for experimental research and medical applications. Most antibodies a...
The camelid-derived single chain antibody (sdAb), also termed VHH or nanobody, is a unique, function...
Nanobodies are antibody-derived therapeutic proteins that contain the unique structural and function...
Engineered monoclonal antibody fragments have gained market attention due to their versatility and t...
Sera of camelid species contain a special kind of antibody that consists only of heavy chains. The v...
In addition to conventional antibodies (with heavy and light chains), camelids also produce function...
Antibodies are important tools for experimental research and medical applications. Most antibodies a...
Tremendous effort has been expended over the past two and a half decades to understand many aspects ...
peer reviewedBackground: The discovery of functional heavy chain-only antibodies devoid of light cha...
© 2020 Cheloha et al. Published under exclusive license by The American Society for Biochemistry and...
Single-domain antibodies, derived from camelid heavy antibodies (nanobodies) or shark variable new a...
Nanobodies (or variable domain of the heavy chain of the heavy-chain antibodies, VHHs) are single-do...
Camelids produce functional antibodies devoid of light chains of which the single N-terminal domain ...
Camelids produce functional antibodies devoid of light chains of which the single N-terminal domain ...
The discovery of heavy-chain-only antibodies (HCAbs) in camelids and sharks led to the rise of a new...
Antibodies are important tools for experimental research and medical applications. Most antibodies a...
The camelid-derived single chain antibody (sdAb), also termed VHH or nanobody, is a unique, function...
Nanobodies are antibody-derived therapeutic proteins that contain the unique structural and function...
Engineered monoclonal antibody fragments have gained market attention due to their versatility and t...
Sera of camelid species contain a special kind of antibody that consists only of heavy chains. The v...
In addition to conventional antibodies (with heavy and light chains), camelids also produce function...
Antibodies are important tools for experimental research and medical applications. Most antibodies a...
Tremendous effort has been expended over the past two and a half decades to understand many aspects ...
peer reviewedBackground: The discovery of functional heavy chain-only antibodies devoid of light cha...
© 2020 Cheloha et al. Published under exclusive license by The American Society for Biochemistry and...
Single-domain antibodies, derived from camelid heavy antibodies (nanobodies) or shark variable new a...
Nanobodies (or variable domain of the heavy chain of the heavy-chain antibodies, VHHs) are single-do...